STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-05-24
Here’s whether Bio-Techne Corp. (TECH) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: RSI 38 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-3.48% over 10 days); 3-month momentum negative (-16.3%). Currently 33.2% off its 52-week high. Score: -4/7.
TECH is trading below its 200-day MA ($57.60) — a key warning sign the longer-term trend is under pressure. An RSI of 38.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +1.9% compares to +27.9% for SPY (trailed the market by 26.0%). The current 33.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $10,188 today
vs. S&P 500 (SPY) — same period trailed market by 26.0%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($57.60)
✗Above 50-day MA ($52.31)
✓RSI(14) neutral zone (30–70) — currently 38.0
✓Positive return (+1.9%)
!Within 10% of period high (−33.2%)
Period Range $48.21
$43.20$72.16
RSI (14) 38.0
0 · OversoldOverbought · 100
Key Metrics
Price$48.21
Period Return+1.9%
Period High$72.16
Period Low$43.20
Drawdown−33.2%
MA-50$52.31
MA-200$57.60
RSI (14)38.0
Avg Volume (30d)2.9M
vs. SPYtrailed by 26.0%
Return Rank#718 of 1236
Trend Signals
Price is below the 200-day moving average ($57.60)